![](/img/cover-not-exists.png)
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study
De Montalembert, Mariane, Abboud, Miguel R., Fiquet, Anne, Inati, Adlette, Lebensburger, Jeffrey D., Kaddah, Normeen, Mokhtar, Galila, Piga, Antonio, Halasa, Natasha, Inusa, Baba, Rees, David C., HeatVolume:
62
Language:
english
Journal:
Pediatric Blood & Cancer
DOI:
10.1002/pbc.25502
Date:
August, 2015
File:
PDF, 715 KB
english, 2015